These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7338554)

  • 21. Histocompatibility types and measles antibodies in multiple sclerosis.
    Fewster ME; Myers LW; Ellison GW; Walford RL
    J Neurol Sci; 1977 Nov; 34(2):287-96. PubMed ID: 925715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anamnestic studies in multiple sclerosis: a relationship between familial multiple sclerosis and neoplasia.
    Sibley WA; Bamford CR; Laguna JF
    Neurology; 1978 Sep; 28(9 Pt 2):125-8. PubMed ID: 568746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
    Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
    Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.
    Goris A; Pauwels I; Gustavsen MW; van Son B; Hilven K; Bos SD; Celius EG; Berg-Hansen P; Aarseth J; Myhr KM; D'Alfonso S; Barizzone N; Leone MA; Martinelli Boneschi F; Sorosina M; Liberatore G; Kockum I; Olsson T; Hillert J; Alfredsson L; Bedri SK; Hemmer B; Buck D; Berthele A; Knier B; Biberacher V; van Pesch V; Sindic C; Bang Oturai A; Søndergaard HB; Sellebjerg F; Jensen PE; Comabella M; Montalban X; Pérez-Boza J; Malhotra S; Lechner-Scott J; Broadley S; Slee M; Taylor B; Kermode AG; Gourraud PA; ; Sawcer SJ; Andreassen BK; Dubois B; Harbo HF
    Brain; 2015 Mar; 138(Pt 3):632-43. PubMed ID: 25616667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HLA and familial multiple sclerosis].
    Barroche G; Perrier P; Raffoux C; Gehin P; Streiff F; Weber M
    Rev Neurol (Paris); 1986; 142(10):738-45. PubMed ID: 3823705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C1q microtiter plate ELISA system for detecting circulating immune complexes and its application of testing the sera in neurological diseases.
    Araga S; Irie H; Takahashi K
    Jpn J Exp Med; 1984 Feb; 54(1):23-7. PubMed ID: 6384588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of circulating immune complexes in plasma of MS patients.
    Wiederkehr F; Büeler MR; Vonderschmitt DJ
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):126-9. PubMed ID: 1710383
    [No Abstract]   [Full Text] [Related]  

  • 28. Absence of brain antibodies in the sera of relapsing-remitting multiple sclerosis patients is not due to the formation of immune complexes.
    Henneberg AE; Elsner U; Kornhuber HH
    Acta Neurol Scand; 1993 Jun; 87(6):455-6. PubMed ID: 8356873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
    J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Circulating immune complexes in multiple sclerosis].
    Hrazdira CL; Hrazdirová V; Polcáková M
    Cesk Neurol Neurochir; 1984 May; 47(3):173-6. PubMed ID: 6467415
    [No Abstract]   [Full Text] [Related]  

  • 31. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
    Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histocompatibility antigens in familial multiple sclerosis in a high-risk area of the disease.
    Kinnunen E; Koskimies S; Lagerstedt A; Wikström J
    J Neurol Sci; 1984 Aug; 65(2):147-55. PubMed ID: 6592288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
    Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
    Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF immune complexes in multiple sclerosis.
    Coyle PK
    Neurology; 1985 Mar; 35(3):429-32. PubMed ID: 2579355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes.
    Madigand M; Oger JJ; Fauchet R; Sabouraud O; Genetet B
    J Neurol Sci; 1982 Mar; 53(3):519-29. PubMed ID: 6978384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating immune complexes in multiple sclerosis. Relation to clinical and biological parameters.
    Davous P; Jacque CM; Grangeot-Keros L; Marteau R; Baumann N
    Biomedicine; 1978 May; 29(3):103-6. PubMed ID: 687746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticomplementary activity in multiple sclerosis.
    Ryberg B
    J Neurol Sci; 1983 May; 59(2):175-83. PubMed ID: 6854348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating immune complexes in multiple sclerosis and other neurological diseases.
    Tachovsky TG; Lisak RP; Koprowski H; Theofilopoulos AN; Dixon FJ
    Lancet; 1976 Nov; 2(7993):997-9. PubMed ID: 62267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody response to different antigenic sites on measles virus surface polypeptides in patients with multiple sclerosis.
    Mäkelä MJ
    J Neurol Sci; 1989 Apr; 90(2):239-46. PubMed ID: 2470864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.